An Open-Label Study to Evaluate Switching from an SSRI or SNRI to Tiagabine to Alleviate Antidepressant-Induced Sexual Dysfunction in Generalized Anxiety Disorder

By Schwartz Thomas   Nasra George   Ashton Adam   Kang David   Kumaresan Hari   Chilton Mark   Bertone Francesca  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 1, 2007-01 ,pp. : 25-30

Informa Healthcare

Access to resources Recommend Favorite

Open-Label Dosage and Tolerability Study of Tiagabine Monotherapy in Patients with Refractory Complex Partial Seizures

By Schachter S.C.   Cahill W.T.   Wannamaker B.B.   Shu V.S.   Sommerville K.W.  

Journal of Epilepsy, Vol. 11, Iss. 5, 1998-09 ,pp. : 248-255

Elsevier

Access to resources Recommend Favorite

Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study

By Braunig Peter   Sacchetti Emilio   Medori Rossella  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 1, 2008-01 ,pp. : 74-77

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Nefazodone Treatment of Adolescent Depression: An Open-Label Study of Response and Biochemistry

By Goodnick P.J.   Jorge C.A.   Hunter T.   Kumar A.M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 12, Iss. 2, 2000-06 ,pp. : 97-100

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Somatization Disorder with Nefazodone: A Prospective, Open-Label Study

By Menza M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 153-158

Springer Publishing Company

Access to resources Recommend Favorite